Form 483

Vetter Pharma Fertigung GmbH & Co. KG (Langenargen Eisenbahnstrasse) Form 483, 2016-04-26

FDA issued a Form 483 to Vetter Pharma Fertigung GmbH & Co. KG (Langenargen Eisenbahnstrasse) on 2016-04-26 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Vetter Pharma Fertigung GmbH & Co. KG (Langenargen Eisenbahnstrasse) · Langenargen, Germany · Issued April 26, 2016

Overview

  • 6 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

26 Apr 2016
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Sharon K Thoma, Liatte Krueger

26 Apr 2016
21 CFR 211.198(a)

Complaint Handling Procedure

Cited by Sharon K Thoma, Liatte Krueger

26 Apr 2016
21 CFR 211.100(b)

Procedure Deviations Recorded and Justified

Cited by Sharon K Thoma, Liatte Krueger

26 Apr 2016
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Sharon K Thoma, Liatte Krueger

26 Apr 2016
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Sharon K Thoma, Liatte Krueger

Inspected site

Inspection team

LKLiatte Krueger

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere